Cerebrovascular disease associated with sickle cell pulmonary hypertension.
about
Preoperative blood transfusions for sickle cell diseaseRed blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviewsChronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive painDistinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in ZambiaReversible posterior leukoencephalopathy syndrome in sickle-cell anemia.How I manage priapism due to sickle cell disease.Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years.Sickle cell disease: a neglected chronic disease of increasing global health importanceVasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directionsPleiotropic effects of intravascular haemolysis on vascular homeostasis.Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disordersAssociated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobinRelative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiencyRedox-dependent impairment of vascular function in sickle cell disease.Interventions for preventing silent cerebral infarcts in people with sickle cell disease.A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia.Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidinElevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation.Definitions of the phenotypic manifestations of sickle cell diseaseArterial ischemic stroke in children: risk factors and etiologies.Interventions for chronic kidney disease in people with sickle cell disease.Advances in understanding the pathogenesis of cerebrovascular vasculopathy in sickle cell anaemia.Interventions for chronic kidney disease in people with sickle cell disease.Association of circulating transcriptomic profiles with mortality in sickle cell disease.Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.Serum lactate dehydrogenase activity as a biomarker in children with sickle cell disease.Nocturnal oxyhemoglobin desaturation and arteriopathy in a pediatric sickle cell disease cohort.Association between Pulmonary Hypertension and Clinical Outcomes in Hospitalized Sickle Cell Disease Patients.Interventions for preventing silent cerebral infarcts in people with sickle cell disease
P2860
Q24185919-376B9887-FE96-481A-9AA0-F3356CFEE677Q24186232-BCCDCACA-96EC-4BBC-8274-979EA00019D3Q33332124-62F46549-32C4-40B4-8C82-2844C5883C90Q33393958-2996437B-1253-47F9-A1DF-1D4717DBCF73Q33993961-4CCA399C-9724-4CBC-B423-193FAD4E1DA6Q34321121-0DB8C724-C8E3-481A-AE6C-7AB901DC5C95Q34579250-8EDE582B-E72E-4FBF-AA83-5A31979033E2Q34806446-79305A63-33AB-4B27-9C49-960A1955CBD0Q34852524-6C94203F-6941-4038-BDF9-DE10377FA023Q34992760-C1B469CC-6DEC-435C-BD7C-25B13F033760Q35535204-1E597CE4-9E8F-44A7-B7AA-B6A4E94E82C9Q35590733-6CD796BE-6015-4E98-81EF-801024E38A9BQ35909642-F6014A30-0973-43B4-A062-8229080ED89CQ35990633-272FD7E5-9F07-4B53-BB21-4613BBF26517Q36100581-FEBBF1C4-91AC-4A78-A93F-EB9054AA900EQ36274222-FFD2AB2D-A7A2-4EE6-A9BC-241479E7DC86Q36370980-9749C82A-0504-46A2-944A-DF44B1987D26Q36528046-732C2274-D475-49EA-BB39-504B00D0FC84Q36862359-8ABBAF62-D126-4431-9DD1-3123D85FAFFEQ37112890-6FDDEC01-EA8A-4E4C-82D6-29B4F9A280E2Q37304326-6D6CCE22-5524-4A09-A57E-E21672F99871Q37637900-E42CCAF1-E39A-4EFE-93A6-B63E918D073BQ37713880-BFC4DC42-A14E-4D7B-94DE-555094222B88Q38089946-5E60B0CD-5AD4-450E-B356-BFC416B7BD72Q38696578-C798DF2D-DC5E-4D67-AD8D-9F7A4BE3F7CFQ38857629-7EEA6879-BC91-423F-8DD5-0000ECA4F18FQ42575662-73954D95-FD05-48F2-BE81-48808B418B32Q43180474-59836277-D4FD-47F7-93F6-5F56A4EDD64AQ46344026-9D2AF7F8-B213-4A38-B95F-DDC1E8756AFAQ46889562-BE753DB8-77A5-4357-8C5D-39539A48C0E8Q47424061-3E95F4F7-2FC8-40C1-9C87-E91330986D4FQ52719836-5A0FECE3-F0E7-4056-8B94-A503881A6044Q57689825-C070B47D-BD03-491E-BFFC-E96A9B5F0152
P2860
Cerebrovascular disease associated with sickle cell pulmonary hypertension.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Cerebrovascular disease associated with sickle cell pulmonary hypertension.
@ast
Cerebrovascular disease associated with sickle cell pulmonary hypertension.
@en
type
label
Cerebrovascular disease associated with sickle cell pulmonary hypertension.
@ast
Cerebrovascular disease associated with sickle cell pulmonary hypertension.
@en
prefLabel
Cerebrovascular disease associated with sickle cell pulmonary hypertension.
@ast
Cerebrovascular disease associated with sickle cell pulmonary hypertension.
@en
P2093
P2860
P50
P356
P1476
Cerebrovascular disease associated with sickle cell pulmonary hypertension.
@en
P2093
Jane Little
John Tisdale
Matthew Hsieh
Roberto Machado
Tanya Lehky
P2860
P304
P356
10.1002/AJH.20642
P577
2006-07-01T00:00:00Z